Citadel Advisors - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 34 filers reported holding ETON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$120,096
-16.3%
28,800
-30.0%
0.00%
Q2 2023$143,516
+20.6%
41,122
+33.0%
0.00%
Q1 2023$119,000
+183.3%
30,909
+55.6%
0.00%
Q3 2022$42,000
-82.1%
19,859
-77.7%
0.00%
Q2 2022$234,000
-17.6%
89,175
+37.0%
0.00%
Q1 2022$284,000
-35.6%
65,100
-36.6%
0.00%
Q4 2021$441,000
-33.4%
102,640
-21.9%
0.00%
Q3 2021$662,000
-7.8%
131,446
+13.0%
0.00%
Q2 2021$718,000
+697.8%
116,375
+923.3%
0.00%
Q3 2020$90,00011,3720.00%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,040,000$32,845,0004.29%
AWM Investment Company, Inc. 971,681$7,900,0001.00%
Diametric Capital, LP 51,633$420,0000.33%
Mesirow Financial Investment Management, Inc. 1,046$8,504,0000.03%
Hood River Capital Management LLC 76,397$621,0000.02%
Westside Investment Management, Inc. 83,900$4,743,0000.01%
MML INVESTORS SERVICES, LLC 129,250$1,051,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 31,961$260,0000.01%
TWO SIGMA INVESTMENTS, LP 126,490$1,028,0000.00%
SEI INVESTMENTS CO 76,397$621,0000.00%
View complete list of ETON PHARMACEUTICALS INC shareholders